Martin A. Kononov
Managing Director, Consulting, Oxford University Biotech Society
Martin is an Ellison Scholar and DPhil student at the Kennedy Institute of Rheumatology, University of Oxford, where he studies T cell tolerance in autoimmunity. His work focuses on next-generation therapies that identify cell states and tune T cell responses to self-antigen. He earned a BS in Chemistry from Brown University, researching chemical probes for reactive sulfur species with Dr. Ming Xian and cardiac regeneration with Dr. Frank Sellke. He later worked with Dr. George Daley at Harvard Medical School on improving T cell differentiation from induced pluripotent stem cells. Martin is Managing Director of Consulting at the Oxford University Biotech Society.
Events Martin A. Kononov has spoken at
- London Biotechnology Show 2026 18 November 2026 – 19 November 2026